Ann: Patrys Expands Executive Management Team , page-3

Do not despair on the share price. These types of stocks cannot get funding other than issuing shares. The shares are issued (say to hedge funds) who want their 30% or so profit. These funds will then sell down all their issued shares to recoup their investment then profit on the way their deal is written.
If the biotech , in this case Patrys is successful it instantly becomes a multi billion dollar company, in the event that it does not succede, then it fizzes out into nothing after all the money has been spent.
The funder (lender) is not really interested in success but uses the borrower to make an assured profit. Should the borrower be successful then it makes a bonanza. A win win for the lender.
Shareholders may become dissillusioned at the way that the share prices are depressed by the lenders to the company, for instance there is currently one large seller that will meet any buyer ( to a degree I suppose) until they have recouped their lending outlay and only then will the share price rise.
CSL was once such a company, no? need any more be said?